Conference Call Announcement by Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc. has exciting news to share with its stakeholders. The biopharmaceutical company is set to host a conference call that will focus on its financial results for the second quarter of 2025. This event is scheduled for a date with particular importance for investors and analysts alike.
Details of the Upcoming Conference Call
The conference call is scheduled to take place at 8:30 a.m. ET on a significant Thursday. Participants will have the opportunity to listen live via phone by pre-registering for the call. Detailed instructions regarding the call's registration process will be available to ensure easy access for all interested parties.
Access to the Call and Webcast
For those who prefer a visual component, Apellis will be offering a live audio webcast of the event, which will feature slides explaining their financial performance and strategic goals. This webcast can be conveniently accessed through the company's official website in the 'Investors and Media' section. After the conference, a replay of the webcast will remain available for a limited time, allowing anyone who missed the live event to catch up on what was discussed.
About Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc. is dedicated to pioneering treatments that target various diseases. The company focuses on innovative therapies that address the complement system, a crucial part of the immune response. With groundbreaking advancements leading to two approved medications aimed at treating conditions that significantly impact patients' lives, Apellis continues to prove its commitment to the field of biopharmaceuticals.
Investor Relations and Contact Information
Investors or interested parties looking for further information are encouraged to reach out to the company directly. Neil Carnahan, who spearheads investor relations, can be contacted by email or phone for more personalized inquiries. This openness to communication signifies the company’s dedication to transparency and investor engagement.
Frequently Asked Questions
What is the focus of the upcoming conference call?
The conference call will focus on discussing Apellis Pharmaceuticals' financial results for the second quarter of 2025.
When will the conference call be held?
The conference call is scheduled for a specific Thursday at 8:30 a.m. ET.
How can investors access the live call?
Investors can pre-register for the call to access it by phone or join the live audio webcast on the company's website.
Who should I contact for more information about the call?
Neil Carnahan, the investor relations contact, is available for any inquiries regarding the conference call.
What is Apellis Pharmaceuticals known for?
Apellis is known for developing innovative therapies targeting the complement system with approved treatments for serious diseases.